b-ht 958 has been researched along with sk&f-38393 in 1 studies
| Studies (b-ht 958) | Trials (b-ht 958) | Recent Studies (post-2010) (b-ht 958) | Studies (sk&f-38393) | Trials (sk&f-38393) | Recent Studies (post-2010) (sk&f-38393) |
|---|---|---|---|---|---|
| 15 | 0 | 3 | 2,012 | 29 | 242 |
| Protein | Taxonomy | b-ht 958 (IC50) | sk&f-38393 (IC50) |
|---|---|---|---|
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 2.8 | |
| D | Rattus norvegicus (Norway rat) | 0.19 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andén, NE; Grabowska-Andén, M | 1 |
1 other study(ies) available for b-ht 958 and sk&f-38393
| Article | Year |
|---|---|
Stimulation of postsynaptic D2- dopamine receptors by B-HT 958 is revealed by co-treatment with the D1- receptor agonist SKF 38393.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adrenergic alpha-Agonists; Animals; Azepines; Benzazepines; Dopamine Agents; Male; Mice; Motor Activity; Receptors, Dopamine; Reserpine; Sulpiride; Time Factors | 1989 |